We are happy to announce that the summary of the conference held in 2018 in Amsterdam has now been published. It took a while but in the end it summarises well what has been discussed between agencies worldwide with a strong focus on the opinion of EMA and US-FDA.
(a) the necessity of multiple-dose studies in BE testing
(b) BE of transdermal delivery systems
(c) liposomal parenteral preparations.
For more information please visit https://www.sciencedirect.com/science/article/abs/pii/S092809872030172X